< previous issue
next issue >
Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy
Gibson, L.F.; Fortney, J.; Magro, G.; Ericson, S.G.; Lynch, J.P.; Landreth, K.S.
Successful co-treatment with LHRH-agonist for ovarian over-stimulation and cystic formation in premenopausal tamoxifen exposure
Cohen, I.; Tepper, R.; Figer, A.; Flex, D.; Shapira, J.; Beyth, Y.
Differentially expressed genes associated with the metastatic phenotype in breast cancer
Kirschmann, D.A.; Seftor, E.A.; Nieva, D.R.C.; Mariano, E.A.; Hendrix, M.J.C.
Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases
Têtu, B.; Brisson, J.; Lapointe, H.; Wang, C.S.; Bernard, P.; Blanchette, C.
Synergistic action of apoptosis induced by eicosapentaenoic acid and TNP-470 on human breast cancer cells
Yamamoto, D.; Kiyozuka, Y.; Adachi, Y.; Takada, H.; Hioki, K.; Tsubura, A.
Reduced expression of p27Kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation
Han, S.; Park, K.; Kim, H-Y.; Lee, M-S.; Kim, H-J.; Kim, Y-D.
Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors
Ménard, S.; Casalini, P.; Tomasic, G.; Pilotti, S.; Cascinelli, N.; Bufalino, R.; Perrone, F.; Longhi, C.; Rilke, F.; Colnaghi, M.I.
Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion
Asch, H.L.; Winston, J.S.; Edge, S.B.; Stomper, P.C.; Asch, B.B.
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B
Fallowfield, L.J.; Leaity, S.K.; Howell, A.; Benson, S.; Cella, D.
Here are a few pages on the site that we think you may find useful: